A potential coronavirus vaccine funded by Bill Gates is set to begin testing in people, with the first patient expected to get it today
- Healthy volunteers in Philadelphia and Kansas City, Missouri, will begin testing an experimental coronavirus vaccine starting this week.
- Inovio Pharmaceuticals, a small biotech in Pennsylvania, received regulatory clearance to begin testing. The Bill and Melinda Gates Foundation and other nonprofits have poured funding into Inovio’s vaccine project.
- The biotech said it expects to have early safety data by late summer and aims to produce 1 million doses by the end of 2020.
- Visit Business Insider’s homepage for more stories.
A small Pennsylvania biotech company is planning to start injecting healthy volunteers with a potential coronavirus vaccine this week, after having received regulatory clearance to start clinical testing.
Researchers plan to dose the first person on Monday. The experimental vaccine was developed by Inovio Pharmaceuticals, and the effort has received funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.